 | • レポートコード：GIR201109506 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、TDS（経皮デリバリーシステム）の世界市場を調査対象にし、TDS（経皮デリバリーシステム）の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（単層接着剤、多層接着剤、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Adhex Pharma、Teikoku Seiyaku、Toyochem、Harro Hofliger、IBSA Group、Tesa Labtec、Hisamitsu、Pfizer、Teva Pharmaceutical、Endo International、Mylan、Sorrento Therapeutics ・メーカー別販売量、売上、市場シェア ・TDS（経皮デリバリーシステム）の地域別市場分析 ・TDS（経皮デリバリーシステム）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・TDS（経皮デリバリーシステム）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・TDS（経皮デリバリーシステム）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・TDS（経皮デリバリーシステム）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・TDS（経皮デリバリーシステム）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・TDS（経皮デリバリーシステム）の種類別市場規模2015-2020：単層接着剤、多層接着剤、その他 ・TDS（経皮デリバリーシステム）の用途別市場規模2015-2020：病院、クリニック、その他 ・TDS（経皮デリバリーシステム）の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global TDS(Transdermal Delivery Systems) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The TDS(Transdermal Delivery Systems) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
TDS(Transdermal Delivery Systems) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, TDS(Transdermal Delivery Systems) market has been segmented into
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
By Application, TDS(Transdermal Delivery Systems) has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global TDS(Transdermal Delivery Systems) market presented in the report. This section sheds light on the sales growth of different regional and country-level TDS(Transdermal Delivery Systems) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global TDS(Transdermal Delivery Systems) market.
The report offers in-depth assessment of the growth and other aspects of the TDS(Transdermal Delivery Systems) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and TDS(Transdermal Delivery Systems) Market Share Analysis
TDS(Transdermal Delivery Systems) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, TDS(Transdermal Delivery Systems) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the TDS(Transdermal Delivery Systems) sales, revenue and market share for each player covered in this report.
The major players covered in TDS(Transdermal Delivery Systems) are:
Adhex Pharma
Teikoku Seiyaku
Toyochem
Harro Hofliger
IBSA Group
Tesa Labtec
Hisamitsu
Pfizer
Teva Pharmaceutical
Endo International
Mylan
Sorrento Therapeutics
Among other players domestic and global, TDS(Transdermal Delivery Systems) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe TDS(Transdermal Delivery Systems) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of TDS(Transdermal Delivery Systems), with price, sales, revenue and global market share of TDS(Transdermal Delivery Systems) in 2018 and 2019.
Chapter 3, the TDS(Transdermal Delivery Systems) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TDS(Transdermal Delivery Systems) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, TDS(Transdermal Delivery Systems) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe TDS(Transdermal Delivery Systems) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 TDS(Transdermal Delivery Systems) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global TDS(Transdermal Delivery Systems) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single-layer Drug-in-Adhesive
1.2.3 Multi-layer Drug-in-Adhesive
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global TDS(Transdermal Delivery Systems) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global TDS(Transdermal Delivery Systems) Market
1.4.1 Global TDS(Transdermal Delivery Systems) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Adhex Pharma
2.1.1 Adhex Pharma Details
2.1.2 Adhex Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Adhex Pharma SWOT Analysis
2.1.4 Adhex Pharma Product and Services
2.1.5 Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teikoku Seiyaku
2.2.1 Teikoku Seiyaku Details
2.2.2 Teikoku Seiyaku Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teikoku Seiyaku SWOT Analysis
2.2.4 Teikoku Seiyaku Product and Services
2.2.5 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Toyochem
2.3.1 Toyochem Details
2.3.2 Toyochem Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Toyochem SWOT Analysis
2.3.4 Toyochem Product and Services
2.3.5 Toyochem TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Harro Hofliger
2.4.1 Harro Hofliger Details
2.4.2 Harro Hofliger Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Harro Hofliger SWOT Analysis
2.4.4 Harro Hofliger Product and Services
2.4.5 Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 IBSA Group
2.5.1 IBSA Group Details
2.5.2 IBSA Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 IBSA Group SWOT Analysis
2.5.4 IBSA Group Product and Services
2.5.5 IBSA Group TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Tesa Labtec
2.6.1 Tesa Labtec Details
2.6.2 Tesa Labtec Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Tesa Labtec SWOT Analysis
2.6.4 Tesa Labtec Product and Services
2.6.5 Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hisamitsu
2.7.1 Hisamitsu Details
2.7.2 Hisamitsu Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hisamitsu SWOT Analysis
2.7.4 Hisamitsu Product and Services
2.7.5 Hisamitsu TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical SWOT Analysis
2.9.4 Teva Pharmaceutical Product and Services
2.9.5 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Endo International
2.10.1 Endo International Details
2.10.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Endo International SWOT Analysis
2.10.4 Endo International Product and Services
2.10.5 Endo International TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mylan SWOT Analysis
2.11.4 Mylan Product and Services
2.11.5 Mylan TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sorrento Therapeutics
2.12.1 Sorrento Therapeutics Details
2.12.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sorrento Therapeutics SWOT Analysis
2.12.4 Sorrento Therapeutics Product and Services
2.12.5 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global TDS(Transdermal Delivery Systems) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global TDS(Transdermal Delivery Systems) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 TDS(Transdermal Delivery Systems) Manufacturer Market Share in 2019
3.3.2 Top 6 TDS(Transdermal Delivery Systems) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Regions
4.1.1 Global TDS(Transdermal Delivery Systems) Sales and Market Share by Regions (2015-2020)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue and Market Share by Regions (2015-2020)
4.2 North America TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.3 Europe TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.5 South America TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
5.1.1 North America TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
5.1.2 North America TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
5.2 United States TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
5.3 Canada TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
5.4 Mexico TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
6.1.1 Europe TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
6.1.2 Europe TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
6.2 Germany TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.3 UK TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.4 France TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.5 Russia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.6 Italy TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific TDS(Transdermal Delivery Systems) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific TDS(Transdermal Delivery Systems) Revenue and Market Share by Regions (2015-2020)
7.2 China TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.3 Japan TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.4 Korea TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.5 India TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.7 Australia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
8.1.1 South America TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
8.1.2 South America TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
8.2 Brazil TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
8.3 Argentina TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9.3 Turkey TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9.4 Egypt TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9.5 South Africa TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global TDS(Transdermal Delivery Systems) Sales and Market Share by Type (2015-2020)
10.2 Global TDS(Transdermal Delivery Systems) Revenue and Market Share by Type (2015-2020)
10.3 Global TDS(Transdermal Delivery Systems) Price by Type (2015-2020)
11 Global TDS(Transdermal Delivery Systems) Market Segment by Application
11.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
11.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2015-2020)
11.3 Global TDS(Transdermal Delivery Systems) Price by Application (2015-2020)
12 Market Forecast
12.1 Global TDS(Transdermal Delivery Systems) Sales, Revenue and Growth Rate (2021-2025)
12.2 TDS(Transdermal Delivery Systems) Market Forecast by Regions (2021-2025)
12.2.1 North America TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.2 Europe TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.3 Asia-Pacific TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.4 South America TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.5 Middle East & Africa TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.3 TDS(Transdermal Delivery Systems) Market Forecast by Type (2021-2025)
12.3.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2021-2025)
12.3.2 Global TDS(Transdermal Delivery Systems) Market Share Forecast by Type (2021-2025)
12.4 TDS(Transdermal Delivery Systems) Market Forecast by Application (2021-2025)
12.4.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2021-2025)
12.4.2 Global TDS(Transdermal Delivery Systems) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global TDS(Transdermal Delivery Systems) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of TDS(Transdermal Delivery Systems) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global TDS(Transdermal Delivery Systems) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Adhex Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Adhex Pharma TDS(Transdermal Delivery Systems) Major Business
Table 9. Adhex Pharma TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 10. Adhex Pharma SWOT Analysis
Table 11. Adhex Pharma TDS(Transdermal Delivery Systems) Product and Services
Table 12. Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 14. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Major Business
Table 15. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 16. Teikoku Seiyaku SWOT Analysis
Table 17. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Product and Services
Table 18. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Toyochem Basic Information, Manufacturing Base and Competitors
Table 20. Toyochem TDS(Transdermal Delivery Systems) Major Business
Table 21. Toyochem TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 22. Toyochem SWOT Analysis
Table 23. Toyochem TDS(Transdermal Delivery Systems) Product and Services
Table 24. Toyochem TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Harro Hofliger Basic Information, Manufacturing Base and Competitors
Table 26. Harro Hofliger TDS(Transdermal Delivery Systems) Major Business
Table 27. Harro Hofliger TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 28. Harro Hofliger SWOT Analysis
Table 29. Harro Hofliger TDS(Transdermal Delivery Systems) Product and Services
Table 30. Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 32. IBSA Group TDS(Transdermal Delivery Systems) Major Business
Table 33. IBSA Group TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 34. IBSA Group SWOT Analysis
Table 35. IBSA Group TDS(Transdermal Delivery Systems) Product and Services
Table 36. IBSA Group TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Tesa Labtec Basic Information, Manufacturing Base and Competitors
Table 38. Tesa Labtec TDS(Transdermal Delivery Systems) Major Business
Table 39. Tesa Labtec TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 40. Tesa Labtec SWOT Analysis
Table 41. Tesa Labtec TDS(Transdermal Delivery Systems) Product and Services
Table 42. Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 44. Hisamitsu TDS(Transdermal Delivery Systems) Major Business
Table 45. Hisamitsu TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 46. Hisamitsu SWOT Analysis
Table 47. Hisamitsu TDS(Transdermal Delivery Systems) Product and Services
Table 48. Hisamitsu TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Pfizer Basic Information, Manufacturing Base and Competitors
Table 50. Pfizer TDS(Transdermal Delivery Systems) Major Business
Table 51. Pfizer TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 52. Pfizer SWOT Analysis
Table 53. Pfizer TDS(Transdermal Delivery Systems) Product and Services
Table 54. Pfizer TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Major Business
Table 57. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 58. Teva Pharmaceutical SWOT Analysis
Table 59. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Product and Services
Table 60. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Endo International Basic Information, Manufacturing Base and Competitors
Table 62. Endo International TDS(Transdermal Delivery Systems) Major Business
Table 63. Endo International TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 64. Endo International SWOT Analysis
Table 65. Endo International TDS(Transdermal Delivery Systems) Product and Services
Table 66. Endo International TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Mylan Basic Information, Manufacturing Base and Competitors
Table 68. Mylan TDS(Transdermal Delivery Systems) Major Business
Table 69. Mylan TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 70. Mylan SWOT Analysis
Table 71. Mylan TDS(Transdermal Delivery Systems) Product and Services
Table 72. Mylan TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Major Business
Table 75. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Total Revenue (USD Million) (2017-2018)
Table 76. Sorrento Therapeutics SWOT Analysis
Table 77. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Product and Services
Table 78. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global TDS(Transdermal Delivery Systems) Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global TDS(Transdermal Delivery Systems) Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global TDS(Transdermal Delivery Systems) Sales by Regions (2015-2020) (K Units)
Table 82. Global TDS(Transdermal Delivery Systems) Sales Market Share by Regions (2015-2020)
Table 83. Global TDS(Transdermal Delivery Systems) Revenue by Regions (2015-2020) (USD Million)
Table 84. North America TDS(Transdermal Delivery Systems) Sales by Countries (2015-2020) (K Units)
Table 85. North America TDS(Transdermal Delivery Systems) Sales Market Share by Countries (2015-2020)
Table 86. North America TDS(Transdermal Delivery Systems) Revenue by Countries (2015-2020) (USD Million)
Table 87. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Countries (2015-2020)
Table 88. Europe TDS(Transdermal Delivery Systems) Sales by Countries (2015-2020) (K Units)
Table 89. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Countries (2015-2020)
Table 90. Europe TDS(Transdermal Delivery Systems) Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific TDS(Transdermal Delivery Systems) Revenue by Regions (2015-2020) (USD Million)
Table 94. South America TDS(Transdermal Delivery Systems) Sales by Countries (2015-2020) (K Units)
Table 95. South America TDS(Transdermal Delivery Systems) Sales Market Share by Countries (2015-2020)
Table 96. South America TDS(Transdermal Delivery Systems) Revenue by Countries (2015-2020) (USD Million)
Table 97. South America TDS(Transdermal Delivery Systems) Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa TDS(Transdermal Delivery Systems) Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa TDS(Transdermal Delivery Systems) Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Countries (2015-2020)
Table 102. Global TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 103. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2015-2020)
Table 104. Global TDS(Transdermal Delivery Systems) Revenue by Type (2015-2020) (USD Million)
Table 105. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2015-2020)
Table 106. Global TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 107. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2015-2020)
Table 108. Global TDS(Transdermal Delivery Systems) Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global TDS(Transdermal Delivery Systems) Market Share Forecast by Regions (2021-2025)
Table 110. Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global TDS(Transdermal Delivery Systems) Market Share Forecast by Type (2021-2025)
Table 112. Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2021-2025)
Table 113. Global TDS(Transdermal Delivery Systems) Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. TDS(Transdermal Delivery Systems) Picture
Figure 2. Global Sales Market Share of TDS(Transdermal Delivery Systems) by Type in 2019
Figure 3. Single-layer Drug-in-Adhesive Picture
Figure 4. Multi-layer Drug-in-Adhesive Picture
Figure 5. Others Picture
Figure 6. TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Other Picture
Figure 10. Global TDS(Transdermal Delivery Systems) Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey TDS(Transdermal Delivery Systems) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global TDS(Transdermal Delivery Systems) Sales Market Share by Manufacturer in 2019
Figure 31. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 TDS(Transdermal Delivery Systems) Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 TDS(Transdermal Delivery Systems) Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Regions (2015-2020)
Figure 38. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Regions in 2018
Figure 39. North America TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
Figure 40. Europe TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
Figure 42. South America TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
Figure 44. North America TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America TDS(Transdermal Delivery Systems) Sales Market Share by Countries (2015-2020)
Figure 46. North America TDS(Transdermal Delivery Systems) Sales Market Share by Countries in 2018
Figure 47. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Countries in 2018
Figure 49. United States TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Countries (2015-2020)
Figure 54. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Countries in 2019
Figure 55. Germany TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Regions 2019
Figure 62. Asia-Pacific TDS(Transdermal Delivery Systems) Revenue Market Share by Regions 2019
Figure 63. China TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America TDS(Transdermal Delivery Systems) Sales Market Share by Countries in 2019
Figure 70. South America TDS(Transdermal Delivery Systems) Revenue Market Share by Countries in 2019
Figure 71. Brazil TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global TDS(Transdermal Delivery Systems) Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales TDS(Transdermal Delivery Systems) Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales TDS(Transdermal Delivery Systems) Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales TDS(Transdermal Delivery Systems) Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales TDS(Transdermal Delivery Systems) Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales TDS(Transdermal Delivery Systems) Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
経皮・経粘膜ドラッグデリバリーの世界市場 2020年 Market Overview The global Transdermal and Transmucosal Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tr…- 経皮ドラッグデリバリーシステムの世界市場 2020年 Market Overview The Transdermal Drug Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 経肺薬剤送達システムの世界市場 2020年 Market Overview The Pulmonary Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 新ドラッグデリバリーシステムの世界市場 2020年 Market Overview The Novel Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- オキシブチニン経皮システムの世界市場 2020年 Market Overview The global Oxybutynin Transdermal System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oxybutynin Tran…